Liver stiffness scan to predict cancer return after surgery
Part of Cancer, Digestive system clinical trials.
This trial uses a special MRI scan (called MRE) to measure liver stiffness after surgery. The results may help predict if the edge of the removed tumor still has cancer cells and if the cancer might come back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with a liver cancer (hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or cancer that spread to the liver from another organ like the colon)
- You had surgery to remove your liver tumor with the goal of curing the cancer, and the doctor checked the edge of the removed tissue for cancer cells
- If you have primary liver cancer, your liver function must be Child-Pugh class A or B
- You can have a special MRI scan (MRE) 7–14 days after surgery
- You are willing and able to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special MRI scan called 3D magnetic resonance elastography to measure liver stiffness before liver surgery. The goal is to see if this test can help predict surgical risk and outcomes for people with liver cancer or liver metastases.
This trial uses a special MRI scan (3D-MRE) to see how well liver cancer responds to conversion therapy, which aims to shrink tumors enough for surgery. It helps doctors understand if the treatment is working.
This trial uses MR elastography (a special MRI) to measure liver stiffness and check for fibrosis (scarring) without a needle biopsy. It may help guide treatment for chronic hepatitis B.
This trial studies if measuring liver and spleen stiffness can help predict the risk of liver cancer coming back after radiofrequency ablation (RFA), a treatment that uses heat to destroy tumors. It aims to improve follow-up care for people with chronic liver disease and early-stage liver cancer.
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
This trial compares a shorter MRI using a special dye to a CT scan for detecting liver cancer recurrence in people who have been cancer-free for at least two years after surgery or local treatment.
Hear when a new Metastatic Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.